Skip to content
Trial Eligibility
Menu

Cortical Electrophysiology of Response Inhibition in Parkinson's Disease

NCT06234995

This study is recruiting at 2 US sites in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Patients with Parkinson's Disease will be studied before, during, and after a deep brain stimulation implantation procedure to see if the stimulation location and the size of the electrical field produced by subthalamic nucleus (STN) DBS determine the degree to which DBS engages circuits that involve prefrontal cortex executive functions, and therefore have a direct impact on the patient's ability to inhibit actions.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Parkinson Disease

Eligibility basics and study details

Study type
Interventional
Phase
Phase 4
Ages
45 to 75 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Emory University
Last updated on ClinicalTrials.gov
September 3, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Georgia · 2

  • Emory Brain Health Center · Atlanta, GA
  • Emory University Hospital · Atlanta, GA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.